Quick Order Cart

Cat. No. ARG43705

Ager Knockout RAW 264.7 Cell Line

  • Product Type:

    In Stock Cell Lines

  • Species:

    Mus musculus (Mouse)

  • Tissue Source:

    Ascites

  • Disease:

    Leukemia

The Ager Knockout RAW 264.7 Cell Line is a CRISPR/Cas9-edited knockout cell line lacking functional RAGE, the multi-ligand receptor for AGEs, HMGB1, and S100 proteins. Originating from murine RAW 264.7 macrophages, this model enables loss-of-function studies of RAGE-mediated NF-??B and MAPK signaling, oxidative stress, and inflammatory cytokine production. It is an essential tool for investigating macrophage-driven inflammation in diabetic complications, atherosclerosis, and neuroinflammation, as well as for screening RAGE inhibitors using assays like ELISA, luciferase reporters, and cell migration analyses. For ordering or protocols, contact Ascent Research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    RAW 264.7

    Sex of Donor

    Male

    Age

    Adult

    Derived From Site

    In situ; Ascites

    Gene Name

    AGER

    Gene Identifier

    NCBI Gene ID 11596

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Temperature

    37°C

    Atmosphere

    5% COâ‚‚

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The Ager Knockout RAW 264.7 Cell Line is a CRISPR/Cas9-edited murine macrophage cell line with targeted disruption of the Ager gene, eliminating expression of the multi-ligand receptor RAGE. This loss-of-function model enables precise investigation of RAGE-mediated signaling without pharmacological interference. Through CRISPR/Cas9-mediated gene disruption, the Ager locus is rendered nonfunctional, providing an isogenic system for studying RAGE-dependent processes.

The parental RAW 264.7 cell line, derived from BALB/c mouse monocyte/macrophage-like cells, is extensively used to examine macrophage functions including phagocytosis, innate immunity, antigen presentation, and inflammatory cytokine production. These cells are especially valuable for studying LPS/TLR4 signaling and NF-??B activation, mimicking activated macrophage behavior. The Ager knockout derivative maintains these characteristics while permitting dissection of RAGE-specific contributions.

RAGE is a pattern recognition receptor recognizing AGEs, HMGB1, S100A8/A9, S100B, and amyloid-??. Ligand binding recruits mDia1, activating Rho GTPases and downstream kinases. Key pathways include NF-??B (via IKK), MAPK cascades (ERK1/2, p38, JNK) leading to AP-1, PI3K/Akt/mTOR, and JAK/STAT3. RAGE-induced NADPH oxidase generates ROS. Transcriptional targets include TNF-??, IL-6, VCAM-1, ICAM-1, MMP-9, and VEGF. RAGE functionally interacts with TLR2/4 via adaptors MyD88 and TIRAP, amplifying inflammation. In macrophages, RAGE signaling promotes sustained cytokine secretion and oxidative stress.

In RAW 264.7 macrophages, RAGE orchestrates prolonged NF-??B activation and cytokine release upon stimulation with DAMPs. Deletion of Ager removes this signaling arm, enabling clear differentiation of RAGE-dependent versus -independent pathways. The model is ideal for investigating RAGE?CTLR4 crosstalk, given the cells?? robust LPS responses. It also facilitates studies on macrophage migration and phagocytosis in contexts such as diabetic complications, atherosclerosis, and neuroinflammation.

Research applications include mechanistic analysis of RAGE-driven NF-??B and MAPK signaling, screening of RAGE inhibitors, and functional studies in inflammation, cancer, and ischemia-reperfusion injury. The line supports assays such as ELISA for cytokine secretion, NF-??B luciferase reporters, cell migration and invasion assays, co-immunoprecipitation of mDia1, and flow cytometry for RAGE surface expression. Phospho-protein analysis and ROS detection further elucidate oxidative and inflammatory pathways. The Ager Knockout RAW 264.7 Cell Line is a precise tool for both basic and translational research. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)